How much funding does PREPAIR-VAC receive?

The project is scheduled to receive about €6.5 million in total over four years from the EU's Horizon Europe program.

What role does NEC OncoImmunity play?

It uses AI for antigen prediction and virus mutation prediction to develop and design vaccine candidates effective against diverse variants.

What is the goal of PREPAIR-VAC?

It aims to strengthen pandemic preparedness and build a vaccine development pipeline by forming a consortium of European academia, industry, and public health partners.

AI in HealthcareAI Watch (Impress)11h agoOct 27, 2026, 13:00 JST

NEC OncoImmunity joins EU's PREPAIR-VAC vaccine project

Send on LINE

3 Key Points

What happened
NEC OncoImmunity is participating in PREPAIR-VAC, an EU Horizon Europe-funded project with about €6.5 million over four years, using AI for antigen and virus mutation prediction to design vaccine candidates.
Why it matters
The project aims to shorten the time from pathogen data to vaccine design, addressing the difficulty of quickly supplying vaccines when emerging infectious diseases appear.

WHO IT HITSPublic health agencies and vaccine developers preparing for future pandemics may benefit from a faster, more predictive design pipeline, if the consortium delivers on its goals.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, every morning.

Get these free every morning

Context & Analysis

PREPAIR-VAC is funded through Horizon Europe, the EU's research and innovation support program. The project's stated aim is to build a next-generation vaccine development pipeline that can respond quickly to emerging infectious diseases.

Conventional vaccine development takes time from design to verification, which makes rapid supply difficult when a new infectious disease appears. Because viruses can mutate over time, the project argues a faster and more predictive approach is needed.

NEC OncoImmunity's contribution focuses on AI for antigen prediction and virus mutation prediction, including designing vaccine candidates that can address diverse variants. The consortium brings together European partners from academia, industry, and public health to pursue that pipeline.

FAQ

How much funding does PREPAIR-VAC receive?: The project is scheduled to receive about €6.5 million in total over four years from the EU's Horizon Europe program.
What role does NEC OncoImmunity play?: It uses AI for antigen prediction and virus mutation prediction to develop and design vaccine candidates effective against diverse variants.
What is the goal of PREPAIR-VAC?: It aims to strengthen pandemic preparedness and build a vaccine development pipeline by forming a consortium of European academia, industry, and public health partners.

AI Watch (Impress)Read Original Article

Send on LINE

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Get it free

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.